Bulk and single-cell transcriptomic analyses identify PNPT1 as a candidate diagnostic biomarker elevated in tumor-derived epithelial cells in esophageal cancer

PNPT1 encodes PNPase, a mitochondrial exoribonuclease involved in RNA import and degradation. Its expression pattern in esophageal cancer (ESCA), however, remains insufficiently characterized. We assessed PNPT1 across cancer types using TIMER, GEPIA and UALCAN, then examined its diagnostic performance in TCGA-ESCA (184 tumors and 13 normal samples, with analyses stratified by histology) and an independent series of 179 paired esophageal squamous cell carcinoma (ESCC) tumor and normal samples (GSE53625). To investigate the cellular source of the observed signal, we reanalyzed two public single-cell RNA-sequencing cohorts comprising nine patients, using patient-level pseudobulk comparisons and copy-number inference where sufficient normal epithelium was available. PNPT1 differed significantly between tumor and normal tissue in 17 cancer types and was higher in tumors in 13, including ESCA. In TCGA-ESCA, the area under the receiver operating characteristic curve (AUC) was 0.951 (95% CI 0.909–0.984); however, the dataset contained far fewer normal samples than tumors, and cross-validated specificity was 92%. In the balanced esophageal squamous cell carcinoma cohort, the AUC was 0.895 (95% CI 0.867–0.920). Neither cohort showed an association between PNPT1 and overall survival using a median expression split. At single-cell resolution, PNPT1 was higher in tumor-derived than in normal epithelial cells in all three patients with paired tissues. This difference was also observed within G1-phase cells in the two evaluable patients, although patient-level tests were not statistically significant. Copy-number inference in two patients provided only partial support for the marker-based cell classification. These computational findings nominate PNPT1 as a candidate diagnostic marker for esophageal cancer, but independent clinical and experimental validation is needed.

Authors

Institutions

Publication Details

Journal
Frontiers in Bioinformatics
Published
2026-11-16
DOI
https://doi.org/10.3389/fbinf.2026.1979986
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Bulk and single-cell transcriptomic analyses identify PNPT1 as a candidate diagnostic biomarker elevated in tumor-derived epithelial cells in esophageal cancer

Ahmed Mohammed Adam, FaisalA Alzahrani, Ehab M.M. Ali
2 links
Frontiers in Bioinformatics
Esophageal Cancer Research and Treatment
article

Bulk and single-cell transcriptomic analyses identify PNPT1 as a candidate diagnostic biomarker elevated in tumor-derived epithelial cells in esophageal cancer

Ahmed Mohammed Adam, FaisalA Alzahrani, Ehab M.M. Ali
article en

Abstract

PNPT1 encodes PNPase, a mitochondrial exoribonuclease involved in RNA import and degradation. Its expression pattern in esophageal cancer (ESCA), however, remains insufficiently characterized. We assessed PNPT1 across cancer types using TIMER, GEPIA and UALCAN, then examined its diagnostic performance in TCGA-ESCA (184 tumors and 13 normal samples, with analyses stratified by histology) and an independent series of 179 paired esophageal squamous cell carcinoma (ESCC) tumor and normal samples (GSE53625). To investigate the cellular source of the observed signal, we reanalyzed two public single-cell RNA-sequencing cohorts comprising nine patients, using patient-level pseudobulk comparisons and copy-number inference where sufficient normal epithelium was available. PNPT1 differed significantly between tumor and normal tissue in 17 cancer types and was higher in tumors in 13, including ESCA. In TCGA-ESCA, the area under the receiver operating characteristic curve (AUC) was 0.951 (95% CI 0.909–0.984); however, the dataset contained far fewer normal samples than tumors, and cross-validated specificity was 92%. In the balanced esophageal squamous cell carcinoma cohort, the AUC was 0.895 (95% CI 0.867–0.920). Neither cohort showed an association between PNPT1 and overall survival using a median expression split. At single-cell resolution, PNPT1 was higher in tumor-derived than in normal epithelial cells in all three patients with paired tissues. This difference was also observed within G1-phase cells in the two evaluable patients, although patient-level tests were not statistically significant. Copy-number inference in two patients provided only partial support for the marker-based cell classification. These computational findings nominate PNPT1 as a candidate diagnostic marker for esophageal cancer, but independent clinical and experimental validation is needed.

Frontiers in BioinformaticsVol. 6
King Abdulaziz University (SA), Tanta University (EG)
Good health and well-being
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon